Coskun, B. N. Et Al. 2017. THE PREVALENCE AND THE REACTIVATION RATES OF HEPATITIS IN PATIENTS WHO ARE TAKING AN IMMUNESUPRESSIVE AGENT FOR TREATMENT OF A RHEUMATOLOGICAL DISEASE. Annual European Congress of Rheumatology , (Madrid, Spain), 1434-1435.

Coskun, B. N., Yagiz, B., Ermurat, S., Danaci, E. S., Tufan, A. N., & Dalkilic, E., (2017). THE PREVALENCE AND THE REACTIVATION RATES OF HEPATITIS IN PATIENTS WHO ARE TAKING AN IMMUNESUPRESSIVE AGENT FOR TREATMENT OF A RHEUMATOLOGICAL DISEASE . Annual European Congress of Rheumatology (pp.1434-1435). Madrid, Spain

Coskun, B. Et Al. "THE PREVALENCE AND THE REACTIVATION RATES OF HEPATITIS IN PATIENTS WHO ARE TAKING AN IMMUNESUPRESSIVE AGENT FOR TREATMENT OF A RHEUMATOLOGICAL DISEASE," Annual European Congress of Rheumatology, Madrid, Spain, 2017

Coskun, B. N. Et Al. "THE PREVALENCE AND THE REACTIVATION RATES OF HEPATITIS IN PATIENTS WHO ARE TAKING AN IMMUNESUPRESSIVE AGENT FOR TREATMENT OF A RHEUMATOLOGICAL DISEASE." Annual European Congress of Rheumatology , Madrid, Spain, pp.1434-1435, 2017

Coskun, B. N. Et Al. (2017) . "THE PREVALENCE AND THE REACTIVATION RATES OF HEPATITIS IN PATIENTS WHO ARE TAKING AN IMMUNESUPRESSIVE AGENT FOR TREATMENT OF A RHEUMATOLOGICAL DISEASE." Annual European Congress of Rheumatology , Madrid, Spain, pp.1434-1435.

@conferencepaper{conferencepaper, author={B. N. Coskun Et Al. }, title={THE PREVALENCE AND THE REACTIVATION RATES OF HEPATITIS IN PATIENTS WHO ARE TAKING AN IMMUNESUPRESSIVE AGENT FOR TREATMENT OF A RHEUMATOLOGICAL DISEASE}, congress name={Annual European Congress of Rheumatology}, city={Madrid}, country={Spain}, year={2017}, pages={1434-1435} }